Skip to main content

CorWave To Report First Successful In Vivo Survival at 30-Day Milestone with Its Innovative LVAD Cardiac Support Device

By June 28, 2019October 24th, 2024Healthcare

CorWave To Report First Successful In Vivo Survival at 30-Day Milestone with Its Innovative LVAD Cardiac Support Device

https://www.corwave.com/wp-content/uploads/2019/06/20190628_CorWave_PR_US_ASAIO-chronic-preclinical-trial.pdf

Tags:

M&L GROUP

We are a family investment firm that cultivates pioneering ventures into successful enterprises with passion, energy and integrity.

Hospitality
Healthcare
Shipping
Alternatives
Media room
About
Contact

Copyright © 2025 M&L Group. All Rights Reserved. | Legal.

Branding and website design by Stepworks